Therapeutic-Dose Anticoagulation Linked to Lower Mortality in COVID-19
Administration of therapeutic- versus prophylactic-dose anticoagulation with heparins linked to lower mortality in patients hospitalized for COVID-19
Upadacitinib Improves Ulcerative Colitis Outcomes at 12 Months
Risk for composite outcome was lower, including lower risks for intravenous steroid use and colectomy, within 12 months in sensitivity analysis
Fish Oil Supplementation Cuts Measure of Prostate Cancer Progression
Findings seen among men enrolled in one year of active surveillance
FDA Approves Zepbound for Sleep Apnea in Patients With Obesity
In clinical trials, drug helped to improve breathing during sleep and promoted weight loss
Rates of Substance Use Down for Teens in the United States
2024 levels generally holding at pandemic-level lows across substances
Just Over Half of Children Hospitalized With Flu Receive Antivirals
Factors associated with higher odds of antiviral receipt include clinical influenza testing, ICU admission
Tecovirimat No Aid for Time to Lesion Resolution With Mpox
Additionally, interim analysis shows that the antiviral is safe but has no effect on pain among adults with mild-to-moderate clade II mpox
DOJ Alleges CVS Facilitated Unlawful Sales, Violating Federal Opioid Regulations
Antidepressant Use Tied to Reduced Genital Sensitivity
Findings show persistent posttreatment genital hypoesthesia among sexual and gender minority youth with history of antidepressant use
FDA Expands Approval of Vtama to Include Atopic Dermatitis
The nonsteroidal topical treatment is approved for patients 2 years and older
